We are Sorry, This Page doesn't Exist
FSD Pharma begins Phase 1 safety, tolerability study of PEA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
Top-line data from Hepatitis B (Sci-B-Vac®) Phase 3 PROTECT trial expected mid-year 2019 Encouraging early immunogenicity data from GBM Phase 1/2a supports advancing into Part B of the study License and Collaboration with Brii Biosciences, to develop.....»»
: Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study shows
Mixing doses of COVID-19 vaccines increases the risk of mild to moderate side effects when compared with administering two shots of the same vaccine, according to a U.K. trial......»»
Single Shot Of AstraZeneca, Pfizer COVID-19 Vaccines Provide 87% Protection, South Korea Study Shows: Reuters
read more.....»»
The CDC finds no safety risks for pregnant people who get the Pfizer and Moderna COVID-19 vaccines
Looking closely at almost 4,000 vaccinated .....»»
Johnson & Johnson asked other drugmakers to help it study blood-clot risks, and Moderna and Pfizer refused, report says
J&J privately contacted rival drugmakers also producing COVID-19 vaccines to join the study, and only AstraZeneca agreed, WSJ reports. Johnson & Johnson privately contacted other drugmakers producing COVID-19 vaccine to join a study into the p.....»»
AIM ImmunoTech announces safety data from Phase 1 study of Ampligen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
U.S. government to study allergic reactions to COVID-19 vaccines
The National Institutes of Health said Wednesday that it started a clinical study assessing allergic reactions to the mRNA COVID-19 vaccines developed by Moderna Inc. and BioNTech SE /Pfizer Inc. . The aim is to understand who is.....»»
Bio-Path Holdings announce completion of safety run-in stage 2 of phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer study shows COVID-19 vaccine still effective up to 6 months later
There were no serious safety c.....»»
Pfizer and BioNTech say COVID-19 vaccine was 100% effective in Phase 3 trial in adolescents
Pfizer Inc. and German partner BioNTech SE said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in an ea.....»»
BioNTech, Pfizer: "Positive" results of COVID-19 vaccine study in adolescents
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UPDATE: Pfizer and BioNTech say COVID vaccine was 100% effective in Phase 3 trial of adolescents
Pfizer Inc. and German partner BioNTech SE said Wednesday a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 years old showed 100% efficacy and robust antibody responses, an even better result that seen in an.....»»
Pregnant women are protected by the Pfizer and Moderna vaccines - and pass high levels of disease-fighting antibodies on to their babies, study finds
A study from Harvard and MIT found pregnant and lactating women had a strong immune response to the shots, and passed .....»»
Myovant Sciences, Pfizer report "positive" results from Phase 3 Liberty study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer initiates Phase 1 study of PF-07321332 in SARS-CoV-2
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer starts early-stage study of oral COVID-19 treatment
Shares of Pfizer Inc. were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 cl.....»»
AC Immune reports topline AC1-24 Phase 1b immunogenicity, safety results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBI Vaccines begins enrollment of Phase 1/2 clinical study of VBI-2902
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A new lab study shows troubling signs that Pfizer"s and Moderna"s COVID-19 shots could be far less effective against the variant first found in South Africa
A mutation called E484K appeared to help the variant, first found in South Africa, to evade antibodies produced by the vaccines, the authors said. .....»»